Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants

Cancer patients are at major risk of developing venous thromboembolism (VTE), resulting in increased morbidity and economic burden. While a number of theories try to explain its pathophysiology, its risk stratification can be broadly done in cancer-related, treatment–related, and patient-related fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Waqas, Ali, Zeeshan, Amjad, Waseem, Alirhayim, Zaid, Farooq, Hina, Qadir, Shayan, Khalid, Fatima, Al-Mallah, Mouaz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963402/
https://www.ncbi.nlm.nih.gov/pubmed/27517038
http://dx.doi.org/10.3389/fcvm.2016.00024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963402/
https://www.ncbi.nlm.nih.gov/pubmed/27517038
http://dx.doi.org/10.3389/fcvm.2016.00024

Ejemplares similares